Revised forecast
Fiscal year ending March 2027 · Full yearPrevious forecast published 8 May 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document.
In light of recent business trends and other factors, the full-year consolidated earnings forecast announced on 8 May 2026 was revised. Conditions during the interim period were challenging due to shipment delays for some logistics equipment, slowing demand for products for the medical sector, intensifying market competition, and higher costs resulting from the weaker yen, among other factors.
Loss on disposal of fixed assets: ¥125 thousand; total extraordinary losses: ¥125 thousand
| Item | Details |
|---|---|
| Net Sales | Not disclosed → ¥9,700 million |
| Operating profit | Not disclosed → ¥200 million |
| Ordinary income | Not disclosed → ¥250 million |
| Profit attributable to owners of the parent | Not disclosed → ¥180 million |
| Net income per share | Not disclosed → 27.75 Yen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Publication date of previous forecast | 8 May 2026 |
| Reason for the revision | In light of recent business trends and other factors, the full-year consolidated earnings forecast announced on 8 May 2026 was revised. Conditions during the interim period were challenging due to shipment delays for some logistics equipment, slowing demand for products for the medical sector, intensifying market competition, and higher costs resulting from the weaker yen, among other factors. |
| Details and amount of extraordinary loss | Loss on disposal of fixed assets: ¥125 thousand; total extraordinary losses: ¥125 thousand |
| Dividend forecast revision | No change |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The full-year earnings forecast was revised based on recent business trends and other factors. For the interim period, the company cited shipment delays for some logistics equipment, slowing demand for products for the medical sector, intensifying market competition, higher costs due to the weaker yen, and the impact of local-currency appreciation at overseas subsidiaries.